For the first time researchers have succeeded in curing a chronic infection with the hepatitis B virus in a mouse model reports Meaww.
A research collaborative have reported that they have moved closer to a cure for chronic Hepatitis B infection. The team includes:
Helmholtz Zentrum München
Technical University of Munich
University Medical Center Hamburg-Eppendorf
University Hospital Heidelberg
While thus far researchers haven’t been able to control the virus fully, this German-based research team demonstrated that T cell therapy can provide a permanent cure.
The Promise of T Cell Therapy
The German researchers reported “T cell therapy is a promising means to treat chronic hepatitis B virus (HBV) infection and HBV-associated hepatocellular carcinoma (liver cancer),” stated in their paper published in the Journal of Clinical Investigation. The German team will probe deeper to understand the potential of T-cell therapy and subsequently conduct clinical trials along with their partners.
Hepatitis B: A Major Problem
According to the World Health Organization (WHO) an estimated 257 million people are living with hepatitis B virus infection. Hepatitis B r...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).